MyFinsight
Home
Blog
About
Short-term investments
$70,865K
(-37.52%↓ Y/Y)
Cash and cash
equivalents
$13,166K
(-61.79%↓ Y/Y)
Prepaid expenses and
other current assets
$3,595K
(26.05%↑ Y/Y)
Total current assets
$87,626K
(-41.86%↓ Y/Y)
Long-term investments
$45,155K
(42.73%↑ Y/Y)
Operating lease
right-of-use assets
$25,619K
(-1.16%↓ Y/Y)
Property and equipment,
net
$3,999K
(7.27%↑ Y/Y)
Other long-term
assets
$1,177K
(-0.25%↓ Y/Y)
Total assets
$163,576K
(-23.27%↓ Y/Y)
Total liabilities and
stockholders equity
$163,576K
(-23.27%↓ Y/Y)
Total stockholders
equity
$131,112K
(-27.60%↓ Y/Y)
Total liabilities
$32,464K
(1.15%↑ Y/Y)
Accumulated deficit
-$361,186K
(-18.55%↓ Y/Y)
Accumulated other
comprehensive income (loss)
-$331K
(-529.87%↓ Y/Y)
Additional paid-in capital
$492,616K
(1.43%↑ Y/Y)
Operating lease
liabilities, net of current...
$23,825K
(-0.56%↓ Y/Y)
Total current
liabilities
$8,639K
(6.17%↑ Y/Y)
Common stock, 0.0001
par value,...
$13K
(0.00%↑ Y/Y)
Current portion of
operating lease...
$3,991K
(-5.54%↓ Y/Y)
Accrued expenses and
other liabilities
$3,553K
(20.93%↑ Y/Y)
Accounts payable
$1,095K
(12.42%↑ Y/Y)
Back
Back
Balance Sheet
Nautilus Biotechnology, Inc. (NAUT)
Nautilus Biotechnology, Inc. (NAUT)
source: myfinsight.com